Product
VIS171
1 clinical trial
1 indication
Indication
Autoimmune DiseasesClinical trial
A Phase 1, First-in-human, 2-part Study (Part 1 is a Single Ascending Dose in Healthy Participants; Part 2 is a Multiple Ascending Dose Study in Participants With Autoimmune Disease) to Evaluate the Safety, PD and PK of VIS171Status: Terminated, Estimated PCD: 2024-02-15